以岭药业：全资子公司获得盐酸伐昔洛韦片药品注册证书

Core Viewpoint - Yiling Pharmaceutical's wholly-owned subsidiary, Yiling Wanzhou International Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the marketing authorization application of Valaciclovir Hydrochloride Tablets, obtaining the drug registration certificate [1] Group 1 - The approval signifies a significant milestone for Yiling Pharmaceutical in expanding its product portfolio [1] - Valaciclovir Hydrochloride Tablets are expected to enhance the company's competitive position in the antiviral drug market [1] - The drug registration certificate allows the company to commence marketing and distribution of the product in China [1]